C. Enfor<o-'lrmftl-dcole-conlro_, *. >-'ro, !. , I. , I. J. Nu et al., ry 1009 'Spi<.,' ]>fOOOCl< cI, C9, JWH-018. JWH.{I73. HU·nO. !WH·IW, JWH·396. JWH·200 [<Ionl. M y, pp.0-1, 2009.

C. , 4. !. Ci-/-es, /. C9, J. {ii8, J. {i73 et al., Not conl roll. d JWH-OI&, JWII-073

J. Nu, ry rolO petm' _1 contrc>lond addition c>I JWH.{I19. JWH-OH 1't.r>Md for, 2011.

J. W~i and I. Jwh-oe8wh·, WH-149. /W1I-166. mIH1S. /WII- 176, JWH·191

. ~~-'ombo<, Q71, HU· 210 'iwiI,er1.nd -.-control cl ~ ~ mi l e food rqul.tion (5 11, 1010.

B. 1. Barratt, M. Cakic, V. Lenton, and S. , Patterns of synthetic cannabinoid use in Australia, Drug and Alcohol Review, vol.2, issue.2, pp.141-147, 2013.
DOI : 10.1080/17542860903350888

. Disponible-sur, /publications/thematic-papers/spice 3. Lindsay L, White ML. Herbal Marijuana Alternatives and Bath Salts?« Barely Legal » Toxic Highs, Clin Pediatr Emerg Med. déc, vol.13, issue.4, pp.283-91, 2012.

A. Bousquet, Spice : un nouvel enjeu de santé publique? Méd et armées, pp.71-76, 2012.

S. Dunham, P. Hooker, and R. Hyde, Identification, extraction and quantification of the synthetic cannabinoid JWH-018 from commercially available herbal marijuana alternatives, Forensic Science International, vol.223, issue.1-3, pp.1-3241, 2012.
DOI : 10.1016/j.forsciint.2012.09.010

L. Fattore, Beyond THC: The New Generation of Cannabinoid Designer Drugs, Frontiers in Behavioral Neuroscience, vol.5, p.60, 2011.
DOI : 10.3389/fnbeh.2011.00060

M. Schmidt, A. Sharma, F. Schifano, and C. Feinmann, Disponible sur: http://www.emcdda.europa « Legal highs » on the net? Evaluation of UK-based Websites, products and product information, EMCDDA | Perspectives on drugs: synthetic cannabinoids in Europe [Internet]. [cité 29 juin 2014], pp.1-392, 2011.

N. Uchiyama, R. Kikura-hanajiri, J. Ogata, and Y. Goda, Chemical analysis of synthetic cannabinoids as designer drugs in herbal products? 3):31?8. 10, Forensic Sci Int. 20 mai, vol.198, issue.1, 2010.

B. Rolland and L. Karila, New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature, 1126?36. 11. Cottencin O, pp.15-164106, 2011.

D. Zuba, B. Byrska, A. Schneir, J. Cullen, B. Ly et al., Forensic Toxicol. 1 janv 2013 Girls: Synthetic Cannabinoid Intoxication Tendances 84 -Nouveaux produits de synthèse et Internet [Internet]. [cité 1 sept 2014]. Disponible sur: http://www.ofdt.fr/ofdtdev/live/publi/tend/tend84.html 15. Synthetic Cannabinoids in herbal products [Internet]. [cité 29 juin 2014]. Disponible sur: https://www.unodc.org/documents/scientific/Synthetic_Cannabinoids.pdf 16 A survey study to characterize use of Spice products (synthetic cannabinoids) Drug Alcohol Depend, ):296?9. 14):238?41. 17. Tendances n°84 -janvier 2013 -NPS et Internet [Internet], pp.1-3, 2011.

D. Sur-fantegrossi, W. Moran, J. Radominska-pandya, A. Prather, P. Barratt et al., Camp NE. Synthetic Cannabinoids Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to ?9-THC: Mechanism underlying greater toxicity? Life Sci [Internet]. [cité 8 déc 2013]; Disponible sur: http://www.sciencedirect.com/science OFDT -Nouveaux produits de synthèse -recherches thématiques The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products, 292?3. 19, pp.390-393, 2011.

S. Kneisel, V. Auwärter, S. Kneisel, W. Weinmann, R. Zimmermann et al., ?3):58?63. 24 Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction Development and validation of a liquid chromatography?tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples, Spice: A never ending story? Forensic Sci Int):825?35. 25. Dresen S, pp.137-181, 2009.

X. Hu, B. Primack, T. Barnett, R. Cook, E. Gunderson et al., College students and use of K2: an emerging drug of abuse in young persons Herbal Highs: A Case Series and Systematic Review of the Clinical Effects and Biopsychosocial Implications of Synthetic Cannabinoid Use in Humans Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample, 320?6. 30. Winstock AR, Barratt MJ, pp.16-291, 2011.

S. Tuv, H. Krabseth, R. Karinen, K. Olsen, E. Øiestad et al., Prevalence of synthetic cannabinoids in blood samples from Norwegian drivers suspected of impaired driving during a seven weeks period, Accident Analysis & Prevention, vol.62, pp.26-31, 2014.
DOI : 10.1016/j.aap.2013.09.009

K. Seely, J. Lapoint, J. Moran, and L. Fattore, Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids A review of clinical manifestations in adolescent and young adults after use of synthetic cannabinoids The DAWN Report: Drug-Related Emergency Department Visits Involving Synthetic Cannabinoids -SR105-synthetic-marijuana, ):234?43. 33. Brewer TL, Collins M, pp.119-126, 2012.

. Disponible-sur, Drug Misuse Declared: Findings from the 2010/11 British Crime Survey England and Wales -hosb1211.pdf [Internet]. [cité 25 août 2014] Disponible sur: https://www.gov.uk/government Containing Cannabinoids : use and motivation for use agains the backdrop of changing laws, 116333.

. Disponible-sur, WADA-prohibited-list-2014-EN [Internet]. [cité 3 juill 2014]. Disponible sur: http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited- list/2014/WADA-prohibited-list-2014-EN.pdf 40, Heltsley R, vol.39

I. Möller, A. Wintermeyer, K. Bender, M. Jübner, A. Thomas et al., Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls Synthetic Cannabinoid Overdose in a 20-Year-Old Male US Soldier Spice: a new « legal » herbal mixture abused by young active duty military personnel Spicing up the military: Use and effects of synthetic cannabis in substance abusing army personnel, 1139?44. 45. DoD Instruction 1010.01 Disponible sur, 2011.

R. Pertwee, A. Howlett, M. Abood, S. Alexander, D. Marzo et al., International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2, Pharmacological Reviews, vol.62, issue.4, pp.588-631, 2010.
DOI : 10.1124/pr.110.003004

B. Ginsburg, L. Mcmahon, J. Sanchez, M. Javors, S. Gurney et al., Purity of synthetic cannabinoids sold online for recreational use Disponible sur: https://www.gov.uk/government Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs, 66?8. 51. Home Office Circular 21uk.pdf [Internet]. [cité 13 juill 2014] Control of synthetic cannabinoids -Publications -GOV.UK [Internet]. [cité 13 juill 2014]. Disponible sur, pp.53-78, 2009.

D. Jager, A. Warner, J. Henman, M. Ferguson, W. Hall et al., LC???MS/MS method for the quantitation of metabolites of eight commonly-used synthetic cannabinoids in human urine ??? An Australian perspective, Journal of Chromatography B, vol.897, 2012.
DOI : 10.1016/j.jchromb.2012.04.002

T. Sobolevsky, I. Prasolov, G. Rodchenkov, K. Chimalakonda, S. Bratton et al., Detection of JWH-018 metabolites in smoking mixture post-administration urine?3):141?7. 64 Conjugation of synthetic cannabinoids JWH-018 and JWH-073, metabolites by human UDPglucuronosyltransferases Liquid chromatography-tandem mass spectrometry analysis of urine specimens for K2 (JWH-018) metabolites, Forensic Sci Int. 15 juill Drug Metab Dispos Biol Fate Chem. oct J Anal Toxicol. sept, vol.2003935, issue.657, pp.487-95, 2010.

M. Hutter, S. Broecker, S. Kneisel, and V. Auwärter, Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in ???herbal mixtures??? using LC-MS/MS techniques, Journal of Mass Spectrometry, vol.6, issue.1, pp.54-65, 2012.
DOI : 10.1371/journal.pone.0021917

B. Emerson, B. Durham, J. Gidden, L. Jr, and . Jo, Gas chromatography???mass spectrometry of JWH-018 metabolites in urine samples with direct comparison to analytical standards, Forensic Science International, vol.229, issue.1-3, pp.1-31, 2013.
DOI : 10.1016/j.forsciint.2013.03.006

I. Möller, M. Thevis, M. Jübner, J. Beike, and M. Rothschild, In vitro phase I metabolism of the synthetic cannabimimetic JWH-018, Metabolism of JWH-015, JWH-098, JWH-251, and JWH-307 in silico and in vitro: a pilot study for the detection of unknown synthetic cannabinoids metabolites, pp.3621-3657, 2010.

U. Kim, M. Jin, J. Lee, S. Han, M. In et al., Tentative identification of phase I metabolites of HU-210, a classical synthetic cannabinoid, by LC???MS/MS, Journal of Pharmaceutical and Biomedical Analysis, vol.64, issue.65, pp.64-6526, 2012.
DOI : 10.1016/j.jpba.2012.02.007

C. Moran, V. Le, K. Chimalakonda, A. Smedley, F. Lackey et al., Quantitative Measurement of JWH-018 and JWH-073 Metabolites Excreted in Human Urine, Analytical Chemistry, vol.83, issue.11
DOI : 10.1021/ac2005636

L. Brents, L. Franks, J. Moran, and P. Prather, Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors, 4228?36. 73. Rajasekaran M, pp.100-108, 2011.

L. Brents, A. Gallus-zawada, A. Radominska-pandya, T. Vasiljevik, T. Prisinzano et al., Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH- 073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity Simultaneous quantification of 20 synthetic cannabinoids and 21 metabolites, and semi-quantification of 12 alkyl hydroxy metabolites in human urine by liquid chromatography-tandem mass spectrometry, Biochem Pharmacol. 1 avr J Chromatogr A. 31 janv Pharmacol Rev. janv, vol.83132754, issue.752, pp.161-202, 2002.

M. Herkenham, A. Lynn, M. Little, M. Johnson, L. Melvin et al., Cannabinoid receptor localization in brain., Proceedings of the National Academy of Sciences, vol.87, issue.5, pp.1932-1938, 1990.
DOI : 10.1073/pnas.87.5.1932

A. Howlett and J. Shim, Cannabinoid Receptors and Signal Transduction, Disponible sur, pp.207-218, 2000.

M. Herkenham, A. Lynn, M. Johnson, L. Melvin, B. De-costa et al., Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study):563?83. 81. Egertová M, Elphick MR. Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB, J Neurosci Off J Soc Neurosci. févr J Comp Neurol. 26 juin, vol.11422, issue.22, pp.159-71, 1991.

G. Griffin, P. Atkinson, V. Showalter, B. Martin, M. Abood et al., Evaluation of Cannabinoid Receptor Agonists and Antagonists Using the Guanosine-5?-O-(3-[35S]thio)- triphosphate Binding Assay in Rat Cerebellar Membranes Inhalation exposure to smoke from synthetic « marijuana » produces potent cannabimimetic effects in mice Moving around the molecule: Relationship between chemical structure and in vivo activity of synthetic cannabinoids, J Pharmacol Exp Ther. 5 janv Drug Alcohol Depend. 1 déc Life Sci, vol.285126, issue.84, 1998.

J. Teske, J. Weller, A. Fieguth, T. Rothämel, Y. Schulz et al., Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography???tandem mass spectrometry, Journal of Chromatography B, vol.878, issue.27, pp.2659-63, 2010.
DOI : 10.1016/j.jchromb.2010.03.016

V. Auwärter, S. Dresen, W. Weinmann, M. Müller, M. Pütz et al., ???Spice??? and other herbal blends: harmless incense or cannabinoid designer drugs?, Journal of Mass Spectrometry, vol.5, issue.5, pp.832-839, 2009.
DOI : 10.1002/jms.1558

J. Cohen, S. Morrison, J. Greenberg, M. Saidinejad, M. Hermanns-clausen et al., Clinical presentation of intoxication due to synthetic cannabinoids Acute intoxication by synthetic cannabinoids ? Four case reports Acute Intoxication Caused by a Synthetic Cannabinoid in Two Adolescents Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings, 534?44. 91. Mir A, Obafemi A, Young A, Kane C. Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2. Pediatrics. 12 janv, pp.177-81, 2011.

D. Mcquade, S. Hudson, P. Dargan, and D. Wood, First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201, European Journal of Clinical Pharmacology, vol.3, issue.3
DOI : 10.1002/dta.158

J. Eur, A. Schneir, and T. Baumbacher, Convulsions Associated with the Use of a Synthetic Cannabinoid Product Acute kidney injury associated with synthetic cannabinoid use--multiple states, 62?4. 94 MMWR Morb Mortal Wkly Rep. 15 févr, pp.93-101, 2012.

«. Forrester, M. Kleinschmidt, K. Schwarz, E. , Y. A. Hoyte et al., Synthetic Cannabinoid Exposures Reported to Texas Poison Centers A Characterization of Synthetic Cannabinoid Exposures Reported to the National Poison Data System in 2010, 379?89. 96351?8. 97, pp.435-443, 2011.

D. Hurst, G. Loeffler, and R. Mclay, Psychosis Associated With Synthetic Cannabinoid Agonists: A Case Series Every-Palmer S. Synthetic cannabinoid JWH-018 and psychosis: an explorative study, Am J Psychiatry. 1 oct Drug Alcohol Depend. 1 sept, vol.168117, issue.99, pp.2-3152, 2011.

H. Müller, W. Sperling, M. Köhrmann, H. Huttner, J. Kornhuber et al., The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes, Schizophrenia Research, vol.118, issue.1-3, pp.1-3309, 2010.
DOI : 10.1016/j.schres.2009.12.001

U. Zimmermann, P. Winkelmann, M. Pilhatsch, J. Nees, R. Spanagel et al., Withdrawal Phenomena and Dependence Syndrome After the Consumption of « Spice Gold », Dtsch Ärztebl Int. juill, vol.106, issue.27, pp.464-471, 2009.

S. Beuck, I. Möller, A. Thomas, A. Klose, N. Schlörer et al., Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing, Analytical and Bioanalytical Chemistry, vol.21, issue.9, pp.493-505, 2011.
DOI : 10.1016/j.jasms.2010.04.018

M. Jang, Y. W. Choi, H. Chang, H. Lee, S. Kim et al., Monitoring of urinary metabolites of JWH-018 and JWH-073 in legal cases, Forensic Science International, vol.231, issue.1-3, pp.1-313, 2013.
DOI : 10.1016/j.forsciint.2013.03.053

S. Kacinko, A. Xu, J. Homan, M. Mcmullin, D. Warrington et al., Development and Validation of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Identification and Quantification of JWH-018, JWH-073, JWH-019, and JWH-250 in Human Whole Blood, Journal of Analytical Toxicology, vol.35, issue.7, pp.386-93, 2011.
DOI : 10.1093/anatox/35.7.386

J. Poklis, A. D. Wise, L. Wiebelhaus, J. Haggerty, B. Poklis et al., Detection and disposition of JWH-018 and JWH-073 in mice after exposure to ???Magic Gold??? smoke, Forensic Science International, vol.220, issue.1-3, pp.1-391, 2012.
DOI : 10.1016/j.forsciint.2012.02.003

N. Samyn, M. Laloup, D. Boeck, and G. , Bioanalytical procedures for determination of drugs of abuse in oral fluid, Analytical and Bioanalytical Chemistry, vol.50, issue.2, pp.1437-53, 2007.
DOI : 10.1093/jat/25.5.289

C. Coulter, M. Garnier, and C. Moore, Synthetic Cannabinoids in Oral Fluid, Journal of Analytical Toxicology, vol.35, issue.7, pp.424-454, 2011.
DOI : 10.1093/anatox/35.7.424

E. Gallardo, M. Barroso, and J. Queiroz, Current technologies and considerations for drug bioanalysis in oral fluid, Bioanalysis, vol.877, issue.3, pp.637-67, 2009.
DOI : 10.1016/j.jpba.2008.09.044

E. Oiestad, U. Johansen, A. Christophersen, and R. Karinen, Screening of synthetic cannabinoids in preserved oral fluid by UPLC???MS/MS, Bioanalysis, vol.5, issue.18, pp.2257-68, 2013.
DOI : 10.1373/clinchem.2011.164822

P. Amaratunga, C. Thomas, B. Lemberg, and D. Lemberg, Quantitative Measurement of XLR11 and UR-144 in Oral Fluid by LC???MS-MS, Journal of Analytical Toxicology, vol.5, issue.6, pp.315-336, 2014.
DOI : 10.1002/dta.1497

A. Salomone, C. Luciano, D. Corcia, D. Gerace, E. Vincenti et al., Hair analysis as a tool to evaluate the prevalence of synthetic cannabinoids in different populations of drug consumers, Drug Testing and Analysis, vol.218, issue.5, pp.126-160, 2014.
DOI : 10.1016/j.forsciint.2011.10.025

A. Salomone, E. Gerace, D. Urso, F. , D. Corcia et al., Simultaneous analysis of several synthetic cannabinoids, THC, CBD and CBN, in hair by ultra-high performance liquid chromatography tandem mass spectrometry. Method validation and application to real samples, Journal of Mass Spectrometry, vol.165, issue.S1, pp.604-614, 2012.
DOI : 10.1016/j.forsciint.2006.05.024

R. Kronstrand, L. Brinkhagen, C. Birath-karlsson, M. Roman, and M. Josefsson, LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine, Analytical and Bioanalytical Chemistry, vol.200, issue.15, pp.3599-609, 2014.
DOI : 10.1016/j.forsciint.2010.04.003

A. Barnes, S. Young, E. Spinelli, T. Martin, K. Klette et al., Evaluation of a homogenous enzyme immunoassay for the detection of synthetic cannabinoids in urine, Forensic Science International, vol.241, pp.27-34, 2014.
DOI : 10.1016/j.forsciint.2014.04.020

M. Feinberg and . Labo-stat, Guide de validation des méthodes d'analyse, 2009.

P. Kintz, Toxicologie et pharmacologie médicolégales, 1998.

H. Autorité-de-santé-abus, F. Deman-n, and !. , dépendances et polyconsommations : stratégies de soins [Internet]. [cité 1 sept 2014] Disponible sur: http://www.hassante.fr/portail/jcms/c_615021/fr/abus-dependances-et-polyconsommations-strategies-de- soins, p.25, 2014.

O. .. Pharmac-ie-plisenl~-par~~, .. La-spodjomttrie-do-_-_-appüc-o<idicti, <. N. Cii-u, and . Oey, API! :isùlI : M;' ou pointlldMiooI d'y ... udrnique do dtIenion ri de _OOIiroaoax. <10 carlMbinoldeo de OJIII, poncl de J>OIi<nU .. MI pour Q>ftdw, p.1